Searchable abstracts of presentations at key conferences in endocrinology

ea0031oc2.4 | Steroids and thyroid | SFEBES2013

THRA or DIO2 mutations are not a common cause of high bone mass in humans

Gogakos A I , Bassett J H D , Gluer C C , Reid D M , Felsenberg D , Roux C , Eastell R , Williams G R

Mice with dominant-negative mutations of thyroid hormone receptor α1 (TRα1) are euthyroid but display growth retardation and delayed bone age as juveniles and increased bone mass during adulthood, indicating impaired skeletal thyroid hormone responsiveness. The first autosomal dominant mutations affecting TRα1 in humans were recently described in two unrelated children and one parent who were euthyroid apart from a low T4:T3 ratio. Consiste...

ea0028oc1.3 | Young Endocrinologists prize session | SFEBES2012

Effect of selenium status on the skeleton in post-menopausal women: the OPUS study

Gogakos Apostolos , Hoeg Antonia , Murphy Elaine , Mueller Sandra , Reid David , Gluer Claus , Felsenberg Dieter , Roux Christian , Eastell Richard , Koehrle Josef , Schomburg Lutz , Williams Graham

T3-action is regulated by three iodothyronine deiodinases, which contain selenium in the active site. It is proposed that Se availability regulates thyroid function. OPUS is a European population-based prospective cohort study of post-menopausal women in which we showed thyroid function within the upper normal range is associated with reduced bone mineral density (BMD) and increased non-vertebral fracture risk. Using strict exclusion criteria we defined reference ranges for th...

ea0027oc5.4 | Oral Communications (RCN CYP Diabetes Session) | BSPED2011

A network delivered ‘out of hours’ specialist telephone support service for young people and families with type 1 diabetes

Abdullah Nadeem , Van Meijgaarden Birgit , Anand Binu , Arun Sara , Bound Christopher , Cackett Nicola , Pesterfield Claire , Raman Viji , Williams Rachel , Wilson Kate , Acerini Carlo

Background: Guidelines on standards for diabetes care for children with type 1 diabetes (TID) recommend continuous (24 h/7-day-a-week) access to advice from specialist health-care professionals. However, for many diabetes teams, limited resources precludes provision of this service outside normal working hours. The use of regional networks may enable the implementation of safe, high quality and cost-effective support to patients and families ‘out of hours’.<p cla...

ea0021oc4.4 | Bone and parathyroid | SFEBES2009

Rapid screening for novel bone phenotypes in 100 consecutive lines from the Wellcome Trust Sanger Institute Gene Targeting Programme

Gogakos Apostolos , Bassett Duncan , van der Spek Anne , Evans Holly , White Jacqui , Ramirez-Solis Ramiro , Steel Karen , Bradley Allan , Thakker Rajesh , Croucher Peter , Williams Graham

The Wellcome Trust Sanger Institute Gene Targeting Programme is deleting all mouse genes and has already generated 400 knockout mice in a C57/BL6N background with a further 4000 genes targeted in ES cells. Two hundred and fifty new knockouts will undergo limited phenotyping each year. However, the programme lacks a sensitive and sufficiently detailed screen for individual physiological systems, each of which requires high throughput methodology and unique expertise. Thus, we p...

ea0020s24.1 | Environmental pollutants as endocrine disruptors | ECE2009

Environmental chemical and thyroid signalling

Dong Hongyan , Yauk Carole , Wade Mike , Williams Andrew , Rowan-Carroll Andrea , Lee Alice , Panchal Priya , You Seo-Hee , Zoeller R Thomas , Lambert Iain

Despite the recognized importance of thyroid hormones (TH) for normal brain development, little is known about the critical molecular events underlying this role. We investigated the molecular basis of TH action on the developing brain by: (1) comparing genome-wide gene expression patterns in the cerebellum of euthyroid, hypothyroid and hyperthyroid juvenile mice treated with 6-propyl thiouracil or mercapto-methylimidazole /perchlorate using DNA microarrays; and (2) investigat...

ea0019oc30 | Bone and Calcium | SFEBES2009

Mice deleted for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome allele have abnormal parathyroids with increased proliferation rates

Walls G , Bowl M , Jeyabalan J , Reed A , Harding B , Ali A , Bradley K , Wang P , Chen J , Williams B , Teh B , Thakker R

The hyperparathyroidism-jaw tumour (HPT-JT) syndrome, an autosomal dominant disorder, is characterised by the occurrence of parathyroid tumours, often carcinomas, and ossifying fibromata of the jaw. The HPT-JT gene, referred to as HRPT2, is located on chromosome 1q25 and consists of 17 exons that encode a 531 amino-acid protein designated parafibromin. To explore the role of HRPT2 in parathyroid tumourigenesis, we generated two mouse models that comprised a conve...

ea0016p547 | Obesity | ECE2008

Central resistin regulates both hypothalamic and peripheral lipid metabolism in a nutritional dependent fashion

Vazquez MJ , Gonzalez CR , Varela L , Lage R , Tovar SA , Sangiao-Alvarellos S , Williams LM , Vidal-Puig A , Nogueiras R , Lopez M , Dieguez C

Current evidence suggests that the adipocyte-derived hormone resistin (RSTN) regulates both feeding and peripheral metabolism through unclear hypothalamic-mediated mechanisms. Here, we demonstrate by the first time, that the anorectic effect of RSTN is associated to specific changes in the expression of neuropeptides in the arcuate nucleus of the hypothalamus (ARC), namely AgRP, NPY and CART. Very interestingly, RSTN also exerts a deep, nutritional-dependent inhibitory effect ...

ea0015oc36 | Thyroid | SFEBES2008

Increased skeletal mineralisation in mice lacking type 2 iodothyronine deiodinase

Bassett JH Duncan , Boyde Alan , Howell Peter GT , Galliford Thomas M , Archanco Marta , St Germain Donald L , Galton Valerie A , Williams Graham R

The prohormone T4 represents the majority of circulating thyroid hormones, whereas 80% of the active hormone T3 is derived from T4 by the actions of the type 1 and type 2 deiodinase enzymes (D1 and D2). Local generation of T3 by D2 regulates ligand supply to the nuclear T3-receptor in pituitary, brown adipose tissue and brain, and this enzyme is also expressed in bone. Hypothyroidism in children causes delayed bone age and growth retardation, whereas thyrotoxicosis in adults c...

ea0015oc40 | Thyroid | SFEBES2008

Direct actions of T3 in proliferating chondrocytes regulate endochondral ossification and linear growth

Bernstein Nicholas D , Swinhoe Rowan , Kester Monique HA , Archanco Marta , Lu Yan , O'Shea Patrick J , Visser Theo J , Bassett JH Duncan , Williams Graham R

Hypothyroidism causes delayed ossification and growth retardation. T3 stimulates hypertrophic chondrocyte differentiation whereas unliganded T3 receptors (TRs) repress gene expression and maintain cell proliferation in the absence of hormone. During development the type 3 deiodinase enzyme (D3) inactivates thyroid hormones and prevents T3-access to the fetus. At birth diminishing D3 activity and increasing T3 availability triggers the onset of cell differentiation and correlat...

ea0045p70 | Pituitary and growth | BSPED2016

A mutation in eukaryotic translation initiation factor 2 subunit 3 (EIF2S3) associated with a novel syndrome of X-linked hypopituitarism and glucose dysregulation

Gregory Louise , Ferreira Carolina , Williams Hywel , Rahman Sofia , Alatzoglou Kyriaki , Kapoor Ritika , Jones Peter , Hussain Khalid , Gaston-Massuet Carles , Qasim Waseem , Dattani Mehul

Background: EIF2S3 (NM_001415; Xp22.11) mutations have previously been reported in a single pedigree with microcephaly and developmental delay. The gene encodes the eukaryotic translation initiation factor 2 subunit 3 (eIF2γ), the largest of three EIF2 subunits. EIF2 is a heterotrimeric GTP-binding protein, which initiates protein synthesis. It forms a ternary complex, mediating recruitment of initiator methionyl-tRNA to the 40S ribosomal subunit to scan the mRNA...